Back to mobile site

BofA/Merrill Lynch Resumes CME Group (CME) at Buy

November 5, 2018 6:52 AM EST Send to a Friend
BofA/Merrill Lynch analyst Michael Carrier resumes coverage on CME Group (NASDAQ: CME) with a Buy rating and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login